AZ-6197

N/A

Report date: 2022/04/12 11:07:41

NME

Base Information

Drug NameAZ-6197

Drug Alias NameAZ-6197

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors

TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Turkey

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A